CHI3L1表达在chordoma:对免疫治疗干预的影响
Beatrice Campilan1, Christian Godinez1, Jonathan Arditi1
1Department of Neurosurgery, The Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
Cells
|February 26, 2026
概括
胆酶-3样1 (CHI3L1) 在瘤瘤中表达升高,这表明它有可能成为一次性瘤的生物标志物和治疗点,这是一种罕见而具有攻击性的癌症.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 脊髓瘤是罕见的,具有不良预后的侵略性脊髓瘤.
- 目前的治疗方法有限,需要新的治疗点.
- 基因酶-3样1 (CHI3L1) 涉及免疫调节和瘤进展.
研究的目的:
- 为了研究CHI3L1在瘤中的表达和作用.
- 评估CHI3L1作为潜在的生物标志物和治疗瘤的治疗标.
主要方法:
- 基于RNA的分析是在瘤细胞系和瘤样本上进行的.
- 酶相关免疫吸收试验 (ELISA) 用于量化CHI3L1水平.
- 对象表达在瘤细胞,心弦前体和主要与复发性瘤之间进行了比较.
主要成果:
- 与 notochordal 前体相比,CHI3L1 的表达在瘤细胞中显著升高.
- 原发性冠状瘤瘤的CHI3L1表达高于复发性瘤.
- 这些发现表明CHI3L1可能参与心脏瘤的发展.
结论:
- CHI3L1是一个有前途的生物标志物和治疗瘤的治疗标.
- 需要进一步的研究,以了解CHI3L1在免疫逃避中的作用,并开发向疗法.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K


